Analyst Report: EFX

1. EXECUTIVE SUMMARY

Equifax closed at $175.57 on Wednesday October 21, up 16.77% from $150.36 on October 14. Two sessions account for nearly all of the gain: a +7.25% day on October 15 with no confirmed catalyst, and an +11.33% day on October 20, when the company reported third-quarter results. Revenue rose 10% to $1.693bn and adjusted EPS of $2.26 beat the $2.20 analysts expected (TIKR). The company cut full-year revenue guidance by about $80m and guided fourth-quarter EPS below expectations, so the rally followed a print with mixed content. Inference: investors weighed the earnings beat, a higher margin-expansion target and strong mortgage-score data above the weaker top-line outlook. The stock gave back 0.55% on October 21 and sits just below its 200-day average, which leaves the move as a recovery within a year of weak performance (-17.23% year to date).

2. THE CATALYST

Equifax released third-quarter results at 6:30am EDT on October 20 (Equifax press release). The stock closed that session at $176.54, up 11.33%, on volume of 3,986,100 shares, the heaviest of the period shown.

Management credited AI-driven cost efficiencies with recovering most of the gross margin lost on weaker mortgage revenue (Equifax press release). Equifax reaffirmed long-term targets of 7% to 10% organic revenue growth and at least 50bp of annual EBITDA margin expansion (Benzinga).

Pre-market reports conflicted: Tickerspark, citing Yahoo, reported an early dip of about 1%, GuruFocus reported a 7.21% gain to $170, and Yahoo Finance showed +5.6%. The regular session then rallied.

The earlier jump on October 15 (+7.25%, $161.26) has no single identified cause. Quiver Quantitative pointed to a run of mortgage product announcements, including Mortgage Ultimate (launched October 13) and Mortgage Score Select (introduced October 8), and Smartkarma added anticipation of earnings. Quiver itself said no clear catalyst was identifiable, so this explanation is unconfirmed. The brief found no sourced catalyst for October 16 or October 19 (-1.66%) or for the -0.55% session on October 21.

3. COMPANY PROFILE

Equifax is a data, analytics and technology company in the Industrials sector (Consulting Services), with a market cap of $20.63bn. It operates three segments: Workforce Solutions (income and employment verification and payroll-related services), U.S. Information Solutions and International. It co-owns VantageScore with TransUnion and Experian, which are its closest competitors in credit data. Fair Isaac, owner of FICO, is a counterparty and competitor in mortgage scoring.

Recent results show a business growing despite a weak mortgage market. Diversified Markets revenue grew 8% and the new-product Vitality Index was above 17% (Equifax press release). Equifax returned $158m to shareholders in the quarter. The Círculo de Crédito acquisition, at a $750m enterprise value, is expected to close in the fourth quarter of 2026 (Equifax releases). The shares trade on a forward P/E of 18.2 against a trailing 31.1, with a dividend yield of 1.28%.

4. DEEP DIVE ANALYSIS

Do fundamentals justify the move? Partly. The quarter beat on revenue growth and EPS, and the higher margin guide shows cost actions offsetting mortgage weakness. The guidance, however, moved the wrong way on revenue. Benzinga reports mortgage-related revenue is now about $60m below the prior fourth-quarter forecast and roughly $80m below the earlier full-year projection. Equifax expects U.S. mortgage originations to fall 6.5% to 7.5% in 2026 and, if current activity persists, a high-single-digit decline in mortgage transactions in 2027 (Benzinga). Analysts reacted modestly: the average 12-month target slipped to $192.19 from $193.62 across 21 analysts, with consensus still at Buy (TradingView, based on the October 19 close). The October 20 price move exceeds any change in published estimates, which supports reading it as relief after a depressed pre-earnings price. The stock had hit a 52-week low of $137.01 on September 30.

Comparable episodes. On September 29 the shares slid to $141.41 after Goldman Sachs cut its target to $171 from $199 (Neutral) and reports that the FHFA single pricing grid for VantageScore and FICO would pressure bureau economics (Kalkine). That episode ran in the opposite direction on the same mortgage-score theme. A year earlier, a third-quarter 2025 EPS beat of $2.04 was followed by a target cut to $253 from $295 (MarketBeat), so a beat has not prevented target reductions before.

Peer read-across. TransUnion rose 6.2% on October 20 ahead of its October 27 report (TIKR), consistent with a sector move tied to VantageScore and mortgage data. The brief found no sourced explanation for Experian's move. The Industrials peers in the facts panel (BE -0.34%, GEV -1.68%, CAT -1.17%, BA +4.13%, GE -3.63%, VRT -4.79%) have no sourced link to Equifax, and the brief offers no explanation for their moves.

Bull case. VantageScore adoption is growing: about 5% of mortgage loans were securitized with it in September 2026, with volume up 230% since April (Investing.com), and Equifax extended its $1 price through 2028 (TIKR). Equifax estimates a full mortgage recovery could add about $1bn of revenue and $700m of incremental margin dollars (Benzinga). Long-term targets stand, and the forward P/E of 18.2 is low relative to the trailing multiple.

Bear case. Management expects the weak late-third-quarter mortgage market to persist through 2026. The fourth-quarter EPS and revenue guides sit below expectations, full-year EPS guidance is slightly lower, and the FHFA pricing grid remains a threat to bureau economics. Several brokers, including Goldman Sachs, RBC (to $177 from $194, undated) and Bank of America (to $200 from $210, single source), have cut targets.

5. TECHNICAL SNAPSHOT

At $175.57 the shares trade above the 50-day average of $166.75 and just below the 200-day average of $177.42, which the stock has yet to reclaim. The price sits 25.7% below the 52-week high of $236.24 (October 27, 2025) and 28.1% above the 52-week low of $137.01. The nearest support is the October 19 close of $158.57, with the October 15 and 16 closes near $161 just above it. The nearest resistance is the October 20 close of $176.54, followed by the 200-day average. Volume on October 21 was 2,535,600, or 1.57x the 50-session average of 1,613,838, so the pullback of 0.55% came on elevated turnover.

6. RISK FACTORS

• Mortgage volumes: management guides to continued weakness through 2026 and a high-single-digit transaction decline in 2027 if activity holds.
• Fourth-quarter delivery: the EPS guide of $2.07 to $2.17 and revenue growth of 3.5% to 5.4% sit below expectations, which leaves little room for a miss.
• Mortgage-score pricing: the FHFA single pricing grid and Fair Isaac's score pricing remain open issues (Kalkine; a Trefis piece on Fair Isaac pricing appeared October 21 but the brief did not read it).
• Deal execution: the Círculo de Crédito close is expected in the fourth quarter of 2026.
• Unconfirmed items: the cause of the October 15 jump, the dates of the RBC, Needham and Morgan Stanley target cuts, and the Bank of America figure.

Upcoming dates: TransUnion reports third-quarter results on October 27, 2026 (TIKR). The Círculo close is expected in the fourth quarter. The brief did not find a confirmed date for Equifax's fourth-quarter report.

7. ACTIONABLE OUTLOOK

Short term (1-2 weeks). The October 27 TransUnion report is the main scheduled event and gives a read on mortgage data and VantageScore. The shares face resistance at $176.54 and the 200-day average of $177.42, with support near $161 to $158.57. Because the rally came on an earnings print with a guidance cut, the stock is exposed to a retracement if sector news disappoints.

Medium term (1-3 months). Direction depends on mortgage origination data and the fourth-quarter guide being met, with the Círculo close as an additional item. Cost efficiencies supporting margins provide a base for earnings, while revenue guidance stays under pressure. Analyst targets averaging $192.19 sit 9.5% above the current price.

Long term. The thesis is unchanged: Equifax reaffirmed 7% to 10% organic revenue growth and at least 50bp of annual margin expansion, and sees mortgage recovery as a $1bn revenue opportunity. The year-to-date decline of 17.23% reflects mortgage weakness and score-pricing uncertainty that the October 20 report did not resolve. This is analysis, not personal financial advice.